Pictet Asset Management
CHRS icon

Pictet Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Pictet Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,481,848
Closed -$8.26M – 1978
2023
Q4 		$8.26M Buy
2,481,848
+602,392
+32% +$2.01M 0.01% 680
2023
Q3 		$7.03M Buy
+1,879,456
New +$7.03M 0.01% 697